title: Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
abstract: Using genetic interventions, we previously determined that C-C motif chemokine ligand 2 (CCL2) promotes malignant pleural effusion (MPE) formation in mice. Here we conducted preclinical studies aimed at assessing the specific therapeutic potential of antibody-mediated CCL2 blockade against MPE. For this, murine MPEs or skin tumors were generated in C57BL/6 mice by intrapleural or subcutaneous delivery of lung (LLC) or colon (MC38) adenocarcinoma cells. Human lung adenocarcinoma cells (A549) were used to induce MPEs in severe combined immunodeficient mice. Intraperitoneal antibodies neutralizing mouse CCL2 and/or CCL12, a murine CCL2 ortholog, were administered at 10 or 50 mg/kg every three days. We found that high doses of CCL2/12 neutralizing antibody treatment (50 mg/kg) were required to limit MPE formation by LLC cells. CCL2 and CCL12 blockade were equally potent inhibitors of MPE development by LLC cells. Combined CCL2 and CCL12 neutralization was also effective against MC38-induced MPE and prolonged the survival of mice in both syngeneic models. Mouse-specific CCL2-blockade limited A549-caused xenogeneic MPE, indicating that host-derived CCL2 also contributes to MPE precipitation in mice. The impact of CCL2/12 antagonism was associated with inhibition of immune and vascular MPE-related phenomena, such as inflammation, new blood vessel assembly and plasma extravasation into the pleural space. We conclude that CCL2 and CCL12 blockade are effective against experimental MPE induced by murine and human adenocarcinoma in mice. These results suggest that CCL2-targeted therapies may hold promise for future use against human MPE.
authors: Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Achaia, Greece.
authors: Antonia
authors: A
authors: Marazioti
authors: Chrysoula A
authors: CA
authors: Kairi
authors: Magda
authors: M
authors: Spella
authors: Anastasios D
authors: AD
authors: Giannou
authors: Sophia
authors: S
authors: Magkouta
authors: Ioanna
authors: I
authors: Giopanou
authors: Vassilios
authors: V
authors: Papaleonidopoulos
authors: Ioannis
authors: I
authors: Kalomenidis
authors: Linda A
authors: LA
authors: Snyder
authors: Dimitrios
authors: D
authors: Kardamakis
authors: Georgios T
authors: GT
authors: Stathopoulos
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology* / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D018932:Chemokine CCL2 / Q000276:immunology*; D003110:Colonic Neoplasms / Q000150:complications / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018945:Monocyte Chemoattractant Proteins / Q000276:immunology*; D016066:Pleural Effusion, Malignant / Q000209:etiology / Q000378:metabolism / Q000628:therapy*
chemical_list: D057134:Antibodies, Neutralizing; C491224:Ccl12 protein, mouse; D018932:Chemokine CCL2; D018945:Monocyte Chemoattractant Proteins
references: Respiration. 2012;83(5):367-76
references: 22584211
references: Blood. 2000 Jul 1;96(1):34-40
references: 10891427
references: Eur Respir J. 2008 Nov;32(5):1321-7
references: 18614555
references: Cancer Lett. 2007 Jul 8;252(1):86-92
references: 17257744
references: Eur Respir J. 2013 Jun;41(6):1409-18
references: 23018906
references: J Natl Cancer Inst. 2008 Oct 15;100(20):1464-76
references: 18840818
references: Invest New Drugs. 2013 Jun;31(3):760-8
references: 22907596
references: Am J Respir Cell Mol Biol. 2006 Feb;34(2):142-50
references: 16210694
references: Nat Methods. 2012 Jul;9(7):671-5
references: 22930834
references: Ann Thorac Surg. 2012 Aug;94(2):374-9; discussion 379-80
references: 22579398
references: Am Rev Respir Dis. 1985 May;131(5):737-41
references: 3923879
references: Am J Respir Cell Mol Biol. 2013 Aug;49(2):180-9
references: 23492192
references: JAMA. 2012 Jun 13;307(22):2383-9
references: 22610520
references: Am J Respir Crit Care Med. 2008 Jul 1;178(1):3-5
references: 18565960
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Respirology. 2011 Oct;16(7):1020-2
references: 21790880
references: Hum Antibodies. 2007;16(3-4):117-25
references: 18334747
references: Mol Cancer. 2010 Mar 10;9:56
references: 20219102
references: JAMA. 2012 Jun 13;307(22):2432-3
references: 22609878
references: Am J Respir Crit Care Med. 2010 Nov 15;182(10):1273-81
references: 20595227
references: J Exp Med. 2011 Nov 21;208(12):2393-401
references: 22025303
references: Am J Pathol. 2000 Dec;157(6):1893-903
references: 11106562
references: J Exp Med. 1997 Jan 6;185(1):99-109
references: 8996246
references: Am J Respir Crit Care Med. 2012 Sep 15;186(6):487-92
references: 22652027
references: Ann Oncol. 2006 Dec;17(12):1853
references: 16790519
references: Am J Respir Crit Care Med. 2008 Jul 1;178(1):50-9
references: 18388351
references: Cancer Res. 2007 Oct 15;67(20):9825-34
references: 17942913
references: Cytokine Growth Factor Rev. 2010 Feb;21(1):41-8
references: 20005149
references: Lung Cancer. 2011 Aug;73(2):171-5
references: 21227533
references: Cancer Cell. 2004 Oct;6(4):409-21
references: 15488763
references: Nature. 2011 Jun 08;475(7355):222-5
references: 21654748
references: J Exp Med. 2001 Nov 5;194(9):F47-51
references: 11696603
references: Oncogene. 2013 Jan 24;32(4):528-35
references: 22370646
references: Clin Cancer Res. 1999 Nov;5(11):3364-8
references: 10589746
references: Oncogene. 2010 Feb 25;29(8):1093-102
references: 19946335
references: Cancer Res. 2010 Jan 1;70(1):109-18
references: 20028856
references: Neoplasia. 2009 Mar;11(3):298-304
references: 19242611
references: Cancer Res. 2013 Mar 1;73(5):1536-46
references: 23271726
references: Am J Respir Cell Mol Biol. 2011 Feb;44(2):230-7
references: 20395632
references: Respirology. 2011 Jan;16(1):53-63
references: 21044230
references: Nutr Cancer. 2009;61(5):640-8
references: 19838938
references: Carcinogenesis. 2010 Jun;31(6):1010-7
references: 20176658
references: Eur Respir J. 1997 Feb;10(2):476-81
references: 9042652
references: Ann Thorac Surg. 2005 Nov;80(5):1941
references: 16242497
references: Transplantation. 2005 Jul 15;80(1):134-9
references: 16003245